Nature de la demande
Réévaluation du SMR
Service Médical Rendu (SMR)
| Faible |
Le service médical rendu par MEGACE 160 mg est faible dans le traitement palliatif des carcinomes du sein.
|
eNq9mN9v2jAQx9/5K6K8JyEUQToFqo21G1KrMlq0aS+VSQ4wM3bqH0D3188hdKOTs7am3lOU2Lk7+77+3Mnp2XZFvDVwgRnt+XHY9D2gGcsxnff8ye1FkPhn/Ua6RGt0MK0bNsO45XsZQUL0/HI0nAKiIvx2dfkR9P/A/X7DS9l0CZl8Mk9JTMLPSCyuUFHO8dI1w7m3Arlgec8vlNx99VIhuY6iv2H8hyhQBmm0/3I4urxrH35Po9LYC6wqAfwS0bnR6Ixb2cwU50DlAEmYM/5gNp3dtZJup9lMrFxgMQbBFM9ghORixNka55CbPSEiwMrJbJPfAF8TkKUTo/Foma2ElXG0RNsx3A/NQb/XowO5lUEziLuduBWfdOLuSbNl5YofbJVZPHoRUXYXd9rJ6elpNOPRCuZaaYF+gJ7DSKDfpM5nkINlvkaMS0QcZQqLwVPNOfLD4f5ZReRYFAQ9hEtR2G4V4kgPA9dkcLeQcgW3XLOK6D37yz5VhESvjHqyJ4mjiEtQDZiisgYoF2PbjRgwKmFbn1E7BsrtXosYxNuZ/cmomf8jNSU4s8WcBpHSB30yHtZTzjUgPiABE+6OEF8xzdlGvD15DjPtKPpiB89/FNJ2kiTWx+q7FlVNHTpXnBUQaSJhcQxohnTGjkWM1qnZ1KNKnQp01yixDBGoaZUCSwJpZT52ds607+5cVQNGo5/Ob20l80UBf7jZvRpN47z3O9l2eHbBfC3Q2sBfL/fqzL+giW4nJ3Z9oeJmpCykLMS7KNpsNuECiUAgvVmhPlP/owwcVGN3bb2Tkl+1QBVMHYU+rWrk67JmewifawqObXT3/+8baqMPyRUckYuK186oOjx/e1D/6XKdhT16AhZ3bnYdKZKYUVddkZoaLR5XGnRe6QXXgLiezXDNbUutLtOouunpN9KovOXpN34Bm7wFfw==
Ca8jyE8cwXHdTDyk
Écouter
